Recent blog posts
Biological Glossary | What is Cyclopeptide?
Bio Sequence
2 min read
Biological Glossary | What is Cyclopeptide?
31 October 2023
A cyclopeptide is a type of peptide in which the amino acid sequence forms a cyclic rather than a linear structure.
Read →
Biological Glossary | What is Conserved Sequence?
Bio Sequence
2 min read
Biological Glossary | What is Conserved Sequence?
31 October 2023
In biology, conserved sequences refer to molecular sequences with high similarity or identity.
Read →
Toripalimab: FDA Greenlights First made-in-China PD-1 and Its Evolving Competitive Landscape
Bio Sequence
3 min read
Toripalimab: FDA Greenlights First made-in-China PD-1 and Its Evolving Competitive Landscape
31 October 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the toripalimab patent are as follows: Shanghai Junshi Biosciences with 52 applications, Cugene with 30 applications, and Guangzhou Zhiyi Biotech with 16 applications. For more applicants, please refer to the image below.
Read →
Biological Glossary | What is Consensus Sequence?
Bio Sequence
2 min read
Biological Glossary | What is Consensus Sequence?
30 October 2023
In molecular biology and bioinformatics, a consensus sequence is a sequence of DNA, RNA, or protein that represents the most common or typical sequence found in a specific location within a population.
Read →
Biological Glossary | What is Coding Sequence (CDS)?
Bio Sequence
2 min read
Biological Glossary | What is Coding Sequence (CDS)?
30 October 2023
A coding sequence (CDS) is a portion of a gene or an mRNA molecule that specifically codes for a protein.
Read →
The Evolution of Competitive Landscape Behind the Best Pharmaceutical Agent Tirzepatide in 2023
Bio Sequence
3 min read
The Evolution of Competitive Landscape Behind the Best Pharmaceutical Agent Tirzepatide in 2023
30 October 2023
Exploring the changes occurring within the application structure amongst Tirzepatide's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Read →
Contemporary Competitive Scenario: Analyzing Roche's Emergent Product, Trontinemab
Bio Sequence
3 min read
Contemporary Competitive Scenario: Analyzing Roche's Emergent Product, Trontinemab
27 October 2023
Exploring the changes occurring within the application structure amongst Trontinemab's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Read →
Biological Glossary | What are Complementarity-determining regions (CDRs)?
Bio Sequence
2 min read
Biological Glossary | What are Complementarity-determining regions (CDRs)?
27 October 2023
Complementarity-determining regions (CDRs) are essential components of the variable chains found in immunoglobulins (antibodies) and T cell receptors.
Read →
Biological Glossary | What is Attenuator?
Bio Sequence
3 min read
Biological Glossary | What is Attenuator?
27 October 2023
Attenuator in biotechnology refers to a nucleotide sequence in DNA that can lead to premature termination of transcription, a process found in bacteria and archaea.
Read →
Mapping the Evolution of the Competitive Landscape of Mirvetuximab Soravtansine
Bio Sequence
3 min read
Mapping the Evolution of the Competitive Landscape of Mirvetuximab Soravtansine
26 October 2023
In mapping the evolutionary trajectory of the patenting landscape pertaining to Mirvetuximab Soravtansine, it is critical to analyze the strategic approach of the top 10 assignees. There is also a dynamic shift in the competition blueprint that is dictated by the progression of time.
Read →
Biological Glossary | What is Artificial Sequence?
Bio Sequence
5 min read
Biological Glossary | What is Artificial Sequence?
24 October 2023
An artificial sequence is a sequence that is not naturally occurring but created by human manipulation.
Read →
Biological Glossary | What is Aptamer?
Bio Sequence
2 min read
Biological Glossary | What is Aptamer?
24 October 2023
Aptamers are single-stranded DNA or RNA molecules that bind to a specific target molecule.
Read →